Definitive Contract 36C25026C0012
Award Date 10/3/25
Potential Completion Date 10/2/30
Potential Value $387K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Available for Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Indianapolis, IN 46202, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This contract award to Cytopath Biopsy Lab Inc., doing business as Cblpath, is for the provision of ThyroSeq Genomic Classifier Tests. The $70,000.00 firm fixed price contract was awarded by the Veterans Integrated Service Network 6 (VISN 6) of the U.S. Department of Veterans Affairs (VA) on October 1, 2024, with a period of performance through September 30, 2025. Cblpath is a provider of specialized anatomic pathology and molecular diagnostic laboratory services, with extensive experience...
- This is a firm fixed price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Cytopath Biopsy Lab Inc., doing business as Cblpath, to provide ThyroSeq genetic testing services for the VA's Veterans Integrated Service Network (VISN) 22. The $366,000 contract will support thyroid cancer screening and diagnosis programs at VA healthcare facilities in California, New Mexico, Arizona, and other regional locations. The original solicitation was a...
- This is a $710,168.17 firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA), Veterans Integrated Service Network 21, to Cytopath Biopsy Lab Inc. (operating as Cblpath) for the ThyroSeq V3 Classifier CPT molecular diagnostic testing service. The contract has an ultimate completion date of August 4, 2029 and exercises the first option year. This award is not associated with a set-aside program. Cytopath Biopsy Lab Inc. is a for-profit organization...
- This firm-fixed-price purchase order was awarded by the Department of Veterans Affairs Network Contracting Office 6 to Cytopath Biopsy Lab Inc., doing business as Cblpath, for the provision of ThyroSeq genomic classifier testing services. The $710,000.00 contract has a period of performance through December 31, 2024 and will support the VA's cancer screening and diagnosis programs at medical centers in Hampton, Richmond, and Salisbury. Cytopath Biopsy Lab Inc. is an experienced provider of...
- This is a firm fixed-price definitive contract awarded by the Veterans Integrated Service Network 2 (VISN 2) of the U.S. Department of Veterans Affairs (VA) to Cytopath Biopsy Lab Inc., doing business as Cblpath, for THRYOSEQUENCE TESTING services. The contract has a ceiling value of $248,145.69 and a period of performance through August 14, 2021. Cblpath is a provider of specialized anatomic pathology and molecular diagnostic laboratory services, primarily focused on cancer screening and...
- The Department of Veterans Affairs Veterans Health Administration has awarded a $8,000.00 firm fixed price purchase order to Cytopath Biopsy Lab Inc., doing business as Cblpath, for thyroid molecular testing services. Cblpath is a provider of specialized anatomic pathology and molecular diagnostic laboratory services, with experience delivering ThyroSeq genetic testing to support cancer screening and diagnosis programs for the VA and Department of Defense. This contract is not set aside and is...
- This is a $625,500.00 firm fixed price purchase order awarded by the Veterans Integrated Service Network 7 (VISN 7), a regional network of the U.S. Department of Veterans Affairs (VA), to Cytopath Biopsy Lab Inc. (doing business as Cblpath) for Thyroid Molecular Testing services. The contract has an ultimate completion date of April 30, 2029. The contract was awarded on a sole source basis under FAR Part 13.5, as Cytopath Biopsy Lab Inc. is the exclusive manufacturer of the required ThyroSeq...
- This is a firm fixed-price delivery order awarded by the U.S. Department of Veterans Affairs (VA) to Cytopath Biopsy Lab Inc., operating under the trade name Cblpath, for the provision of ThyroSeq molecular diagnostic testing services. The $288,000.00 contract has an ultimate completion date of January 31, 2026 and will support cancer screening and diagnosis programs for veterans and active military personnel. Cytopath Biopsy Lab Inc. is a for-profit organization that specializes in anatomic...
- The U.S. Department of Veterans Affairs (VA) has awarded a Firm Fixed Price Blanket Purchase Agreement (BPA) call to Cytopath Biopsy Lab Inc., doing business as Cblpath, to provide ThyroSeq Genomic Classifier Tests. The contract, valued at $60,000.00, will support the VA's cancer screening and diagnosis programs within its regional healthcare networks. Cytopath Biopsy Lab Inc. is a provider of specialized anatomic pathology and molecular diagnostic laboratory services, with a focus on cancer...
- This is a $294,000.00 firm fixed price Blanket Purchase Agreement (BPA) Call awarded by the Veterans Integrated Service Network (VISN) 19 of the Department of Veterans Affairs (VA) to Cytopath Biopsy Lab Inc., doing business as Cblpath. The contract is for the provision of ThyroSeq molecular diagnostic testing services over the period of performance ending August 31, 2024. The contract provides for Cytopath Biopsy Lab Inc. to deliver ThyroSeq genetic testing to support the VA's thyroid cancer...